Public Release: 

Personalized medicine, future of pharmaceuticals explored in UH lecture

Amalia M. Issa headlines fourth presentation in 'Today's Health' series April 19

University of Houston

HOUSTON, April 14, 2006 - With the potential for reducing or eliminating side effects and improving a patient's recovery, personalized medicine - tailor-made medications based on an individual's genetic information - is revolutionizing the field of drug discovery and development.

Amalia M. Issa, a pharmacologist and clinical epidemiologist, will give a lecture titled "Personalized Medicine and the Future of the Pharmaceutical Industry" at the University of Houston from noon to 1 p.m., Wednesday, April 19 in Room 130 of Science & Research Building Two. The event is free and open to the public and scientific community.

Issa is the director of the Program in Personalized Medicine and Targeted Therapeutics at the Abramson Family Center for the Future of Health, a joint initiative between UH and The Methodist Hospital Research Institute. She is also an associate professor in UH's College of Technology. Her primary interests are in how basic and clinical pharmaceutical sciences are translated into clinical research and practice, as well as health policy.

In addition to discussing how personalized medicine seeks to develop drugs that are customized for an individual patient's particular condition and side-effects profile, Issa will address the shifting terrain of drug discovery and development, the evolving process required for innovative pharmaceuticals, and key challenges and issues facing scientists and the pharmaceutical industry.

This is the fourth in a series of lectures called "Today's Health" - sponsored by the UH Libraries and UH College of Pharmacy - that showcases speakers who focus on the vital role of pharmacists in health care delivery. The concept behind "Today's Health" is to spotlight prominent area health professionals who possess valuable, real-world knowledge and can address topics relevant to pharmacy students, as well as being readily understood by a general audience.

The Abramson Family Center is dedicated to accomplishing the research, prescribing the action and training the people who provide Houston and its surrounding areas with the finest health care available in the world. Its Program in Personalized Medicine and Targeted Therapeutics seeks to promote informed decision-making about the effectiveness of pharmaceutical products, services and policies.

For more information, call Nelda Cervantes at 713-743-1242.

WHO: Amalia M. Issa Pharmacologist and Clinical Epidemiologist Expert in Personalized Medicine and Targeted Therapeutics

WHAT: "Personalized Medicine and the Future of the Pharmaceutical Industry"

WHEN: Noon to 1 p.m. Wednesday, April 19

WHERE: University of Houston Science & Research Building Two, Room 130 Entrance 14 off Cullen Boulevard


For more information about UH, visit the university's Newsroom at

To receive UH science news via e-mail, visit

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.